DEVELOPMENT STATUS IN THE MEADOW OF NANOSTRUCTURE MAGNETIC DRUG DELIVERY SYSTEM AND ITS PROMISING APPLICATIONS
DOI:
https://doi.org/10.22159/ijpps.2017v9i12.21544Keywords:
Magnetic Nanoparticles, Drug delivery system, Applications, Drug targetingAbstract
This article discusses about magnetic nanoparticles, their physico-chemical properties various applications in medicinal sectors and technology advancements. Superparamagnetic, high magnetic susceptibility, non-toxicity, biocompatibility and less Curie temperature are critical characteristics of magnetic nanoparticles which make them suitable for assorted medical applications. Now a day's magnetic particles play significant role in diverse technological areas with potential applications in fields such as electronics, energy biomedicine and diagnosis. Magnetic nanoparticles have been a vivacious topic of extreme research for the last fifty years due to its top-down approaches. The prospective of magnetic nanoparticles stems from the fundamental characteristics of their magnetic cores collective with their drug loading capability, biochemical properties. This article review the modern advancement of magnetic nanoparticles for drug delivery, focusing chiefly on the impending applications like targeted drug delivery, bioseparation, ,magnetic resonance and cancer diagnosis, induction of hyperthermia, induction of hyperthermia, nanorobotic agents ,tissue engineering ,artificial muscle ,magnetically activated polymers, controlled tissue assembly, control cell function, bone regeneration scaffold ,destruction of blood clots ,labeling stem cells with magnetic nanoparticles, implant-assisted intrathecal magnetic drug targeting, biodegradable magnetic nanocomposite stent, local drug delivery etc.
Downloads
References
Pankhurst QA, Connolly J, Jones SK, Dobson. J Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2003;36:167–81.
Pandey P, Dahiya M. A brief review on inorganic nanoparticles. J Crit Rev 2016;3:18-26
Litvinov D, Kolhatkar A, Jamison A, Willson R, Lee T. Tuning the magnetic properties of nanoparticles. Int J Mol Sci 2013;14:15977-6009.
Scott Epstein Magnetic drug targeting and nanoparticle size. Springer Open blog; 2015.
Thodsaphon Lunnoo, Theerapong Puangmali. Capture efficiency of biocompatible magnetic nanoparticles in arterial flow: a computer simulation for magnetic drug targeting nanoscale. Res Lett 2015;10:1-11.
Nagavarma B, Hemant K, Yadav S, Ayaz A, Vasudha S, Shivakumar G. Different techniques for preparation of polymeric nanoparticles-a review. Asian J Pharm Clin Res 2012;5:16-23.
Gozde S Demirer, Aysu C Okur, Seda Kizilel. Synthesis and design of biologically inspired biocompatible iron oxide nanoparticles for biomedical applications. J Materials Chem B 2015;3:7831-49.
Mukesh G Harisinghani, Jelle Barentsz, Peter F Hahn, Willem M Deserno, Shahin Tabatabaei, Christine Hulsbergen van de Kaa, et al. Noninvasive detection of clinically occult lymph node metastases in prostate cancer. New England J Med 2003;348:2491–9.
Hergt R, Dutz S, Muller R, Zeisberger M. Magnetic particle hyperthermia: nanoparticle magnetism and materials development for cancer therapy. J Phys: Condens Matter 2006;18:2919–34.
Vallejo Fernandez G, Whear O, Roca AG, Hussain S, Timmis J, Patel V, et al. Mechanisms of hyperthermia in magnetic nanoparticles. J Physics D: Appl Physics 2013;46:1-6.
Salunkhe AB, Khot VM, Pawar SH. Magnetic hyperthermia with magnetic nanoparticles: a status review. Curr Topics Med Chem 2014;14:572–94.
Lepock JR. Role of nuclear protein denaturation and aggregation in thermal radio sensitization. Int J Hyperthermia 2004;20:115–30.
Ahmed K, Zaidi SF. Treating cancer with heat: hyperthermia as a promising strategy to enhance apoptosis. J Pakistan Med Association 2013;63:504–8.
Hildebrandt B. The cellular and molecular basis of hyperthermia. Critical Rev Oncol/Hematol 2002;43:33–56.
Roti JLR. Cellular responses to hyperthermia (40–46 ° C): Cell killing and molecular events. Int J Hyperthermia 2008;24:3–15.
Kampinga HH, Dikomey E. Hyperthermic radio sensitization: mode of action and clinical relevance. Int J Radiat Biol 2001;77:399–408.
Takahashi A, Yamakawa N, Mori E, Ohnishi K, Ichi Yokota S, Sugo N, et al. Development of thermotolerance requires interaction between polymerase-β and heat shock proteins. Cancer Sci 2008;99:973–8.
Genet SC, Fujii Y, Maeda J, Kaneko M, Genet MD, Miyagawa K, Kato TA. Hyperthermia inhibits homologous recombination repair and sensitizes cells to ionizing radiation in a time-and temperature-dependent manner. J Cellular Physiol 2013;228:1473–81.
Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 2011;30:1-14.
Zoil W, Ricotti L, Tesei A, Barzanti F, Amadori D. In vitro preclinical models for a rational design of chemotherapy combinations in human tumors. Critical Rev Oncol/Hematol 2001;37:69–82.
Cole AJ, Yang VC, David AE. Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol 2011;29:323–32.
Hayashi K, Nakamura M, Sakamoto W, Yogo T, Miki H, Ozaki S, et al. Super paramagnetic nanoparticles clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics 2013;3:366–76.
Duan Y, Zheng J, Han S, Wu Y, Wang Y, Li D, et al. A tumor-targeted gene vector modified with G250 monoclonal antibody for gene therapy. J Controlled Release 2008;127:173–9.
Chen C, Yi Y, Chen C, Wu LF, Song T. Killing of staphylococcus aureus via magnetic hyperthermia mediated by magnetotactic bacteria. Appl Environ Microbiol 2016;82:2219-26.
Ouajdi Felfoul, Mahmood Mohammadi, Samira Taherkhani, Dominic de Lanauze, Yong Zhong Xu, Dumitru Loghin, et al. Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions. Nature Nanotechnol 2016;11:941-7.
Jadczyk T, Tfaily EB, Mishra S, Jędrzejek M, Bołoz M, Parasuraman P, et al. Innovative diagnostics and treatment: nanorobotics and stem cells part of the series springer briefs in applied sciences and technology. 1st ed. Singapore. 2017. p. 37-61.
Ito A, Kamihira M. Tissue engineering using magnetite nanoparticles. Prog Mol Biol Transl Sci 2011;104:355-95.
Demming A. Scaffoldless tissue engineering benefits from combined approach; 2017. Available from: http:// nanotechweb.org/ [Last accessed on 20 Jun 2017]
Penland N, Choi E, Perla M, Park J, Kim D. Facile fabrication of tissue-engineered constructs using nanopatterned cell sheets and magnetic levitation. Nanotechnology 2017;28:75103.
ZrÃnyi M. Intelligent polymer gels controlled by magnetic fields. Colloid Polym Sci 2000;278:98–103.
Zrinyi M, Barsi L, Buki A. Deformation of ferrogels induced by non-uniform magnetic fields. J Chem Physics 1996;104:8750–6.
Morrissey R, Rodriguez-Lorenzo LM, Gross KA. Influence of ferrous iron incorporation on the structure of hydroxyapatite. J Mater Sci: Mater Med 2005;16:387-92.
Sukumaran A, Asala F, Ansar E, Elna P, Varma H, Mohammad D, et al. Drug delivery systems in bone regeneration and implant dentistry. Editors Ilser Turkyilmaz current concepts in dental implantology. InTech; 2015.
Houston Methodist. Magnetic nanoparticles could stop blood clot-caused strokes. Eurek Alert American Association for the Advancement of Science (AAAS); 2015.
Rudolph K. Adult Stem Cells in Aging, Diseases, and Cancer; Karger AG: Basel, Switzerland; 2015.
Stem Cell Information. National Institutes of Health, U. S. Department of Health and Human Services. Available from: http://stemcells.nih.gov/info/basics/pages/basics1.aspx. [Last accessed on 05 Jun 2015]
Yanai A, Hafeli UO, Metcalfe AL, Soema P, Addo L, Gregory-Evans CY, et al. Focused magnetic stem cell targeting to the retina using superparamagnetic iron oxide nanoparticles. Cell Transplant 2012;21:1137–48.
Tukmachev D, Lunov O, Zablotskii V, Dejneka A, Babic M, Sykova E, et al. An effective strategy of magnetic stem cell delivery for spinal cord injury therapy. Nanoscale 2015; 7:3954–8.
Shinozuka K, Dailey T, Tajiri N, Ishikawa H, Kaneko Y, Borlongan CV. Stem cell transplantation for neuroprotection in stroke. Brain Sci 2013;3:239–61.
Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000;18:410–4.
Dodd CH, Hsu HC, Chu WJ, Yang P, Zhang HG, Mountz JD Jr, et al. Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. J Immunol Methods 2001;256:89–105.
Ahrens ET, Feili-Hariri M, Xu H, Genove G, Morel PA. Receptor-mediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo MR imaging. Magn Reson Med 2003;49:1006–13.
Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003;228:480–7.
Nguyen PK, Lan F, Wang Y, Wu JC. Imaging: guiding the clinical translation of cardiac stem cell therapy. Circulation Res 2011;109:962–79.
Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, et al. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004;104:1217–23.
Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, et al. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 2005;18:553–9.
Jasmin, Torres AL, Nunes HM, Passipieri JA, Jelicks LA, Gasparetto EL, et al. Optimized labeling of bone marrow mesenchymal cells with superparamagnetic iron oxide nanoparticles and in vivo visualization by magnetic resonance imaging. J Nanobiotechnol 2011;9:1-13.
Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg 1975;69:685–9.
Gervin AS. Complications of heparin therapy. Surg Gynecol Obstet 1975;140:789–96.
Ali S, Hongbin Z, John KJ, Mu C. Active regulation of on-demand drug delivery by magnetically triggerable micro spouters. Adv Funct Mater 2017;27:1-9.
Shah JS, Shah VA, Joshi DP, Shah VH, Upadhyay U. Magnetisable implants for targeted drug delivery system. Int J Pharm Res Scholars 2012;1:338-45.
Chorny M, Fishbein I, Yellen B, Alferiev I, Bakay M, Ganta S, et al. Targeting stents with local delivery of paclitaxel-loaded magnetic nanoparticles using uniform fields. Proceedings National Academy Sciences United State America 2010;107:8346–51.
Published
How to Cite
Issue
Section
